Significant reduction of sensitization and improved allograft outcome with donor-specific buffy coat transfusion
Okazaki, H.; Takahashi, H.; Miura, K.; Ishizaki, M.; Taguchi, Y.
Transplantation 37(5): 523-525
1984
ISSN/ISBN: 0041-1337 PMID: 6233767 Document Number: 227741
Document emailed within 1 workday
Related Documents
Okazaki, H.; Takahashi, H.; Jimbo, M.; Iguro, T.; Satoh, T.; Ishizak, M. 1989: Transplant outcome with donor specific buffy-coat and lymphocyte-transfused patients Transplantation Proceedings 21(1 Part 2): 1832-1833Schulak, J.A.; Cooke, J.C.; Herrmann, M.J. 1990: Failure of donor irradiation and graft lymph node reduction to prolong pancreas allograft survival in cyclosporine- and donor-specific transfusion-treated hosts Transplantation 50(2): 341-343
Jiang, Y.Z.; Cullis, J.O.; Kanfer, E.J.; Goldman, J.M.; Barrett, A.J. 1993: T cell and NK cell mediated graft-versus-leukaemia reactivity following donor buffy coat transfusion to treat relapse after marrow transplantation for chronic myeloid leukaemia Bone Marrow Transplantation 11(2): 133-138
Goss, J.A.; Nakafusa, Y.; Yu, S.; Flye, M.W. 1993: Reduction in donor-specific cytotoxic T lymphocytes and prolonged cardiac allograft survival following intrathymic donor splenocyte injection Transplantation Proceedings 25(1 Part 1): 286-288
Davies, C.B.; Cofer, B.R.; Alexander, J.W. 1991: Effects of donor-specific transfusion, cyclosporine a and FK 506 on rat cardiac allograft survival Transplantation Proceedings 23(6): 3314-3315
Christiaans, M.H.; van Hooff, J.P.; Nieman, F.; van den Berg-Loonen, E.M. 1999: HLA-DR matched transfusions: development of donor-specific T- and B-cell antibodies and renal allograft outcome Transplantation 67(7): 1029-1035
Ringers, J.; Haanstra, K.G.; Kroczek, R.A.; Kliem, K.; Kuhn, E.M.; Wubben, J.; Ossevoort, M.A.; Volk, H.Dieter.; Jonker, M. 2002: Blockade of CD40-CD154 at the time of donor-specific blood transfusion does not lead to prolonged kidney allograft survival in nonhuman primates Transplantation 73(6): 862-866
Eleftherios C. Vamvakas 2010: The Relative Safety of Pooled Whole-Blood-Derived Platelets Prepared by the Buffy-Coat Method Versus Single-Donor (Apheresis) Platelets Clinical Laboratory 56(7-8): 263-279
Hale, D.A.; Gottschalk, R.; Maki, T.; Monaco, A.P. 1998: Determination of an improved sirolimus (rapamycin)-based regimen for induction of allograft tolerance in mice treated with antilymphocyte serum and donor-specific bone marrow Transplantation 65(4): 473-479
Tchervenkov, J.I.; Epstein, M.D.; Alexander, J.W.; Schroeder, T.J. 1989: The effect of donor-specific blood transfusion, cyclosporine, and dietary prostaglandin precursors on rat cardiac allograft survival. II. Effectiveness of a 24-hour induction period with DST and CsA in inducing long-term graft survival Transplantation 47(1): 177-181
Jaskłowska-Englisz, M.; Olszewski, W.L. 1994: Donor-specific transfusions prolong heart allograft survival but lymphocytes from the same donor are acutely rejected Transplantation Proceedings 26(6): 3463
Rogalle, T.; Doua, F.; Brauet-Noble, G.; Fidier, N.; Buguet, A. 1995: The quantitative buffy coat technique in detecting trypanosomes Medecine Tropicale: Revue du Corps de Sante Colonial 55(3): 288
Mädler, J. 1986: Leukocyte content of erythrocyte concentrates without buffy coat Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 41(13): 372-374
Mirdha, B.R.; Samantray, J.C.; Burman, D.; Mishra, B.; Ghimire, P. 1999: Quantitative buffy coat: a special adjunct for diagnosis of malaria Journal of Communicable Diseases 31(1): 19-22
Singh, H.; Tyagi, P.K.; Sharma, S.K. 2001: Malaria diagnosis: quantitative buffy coat versus conventional microscopy Journal of the Association of Physicians of India 49: 945-946
Polack, B.; Pernod, G.; Mossuz, P.; Vigier, J.P.; Giraud, S.; Kolodié, L. 1995: Validation of electronic cell counts by quantitative buffy coat analysis (QBC) Nouvelle Revue Francaise d'Hematologie 37(3): 179-182
Chapman, J.R.; Wavamunno, M.; O'Connell, P.J.; Nankivell, B.J. 2013: Unravelling the connections between donor specific antibodies and renal allograft pathology Clinical Transplants 2013: 361-365
Romaniuk, A.; Ryffa, T.; Rowiński, W.; Olszewski, W.L. 1989: Prolongation of heart allograft survival in course of donor specific antigen and alloserum treatment in the rat Archivum Immunologiae et Therapiae Experimentalis 37(3-4): 253-260
Hillis, A.N.; Duguid, J.; Evans, C.M.; Bone, J.M.; Sells, R.A. 1987: Three year experience of donor specific transfusion and concomitant cyclosporine a Transplantation Proceedings 19(1 Part 3): 2248-2249
Tanpradist, S.; Tharavanij, S.; Yamokgul, P.; Bualombai, P.; Wongchotigul, V.; Singhasivanon, P.; Patarapotikul, J.; Thammapalerd, N.; Prasittisuk, C.; Tantanasrikul, S. 1995: Comparison between microscopic examination, ELISA and quantitative buffy coat analysis in the diagnosis of falciparum malaria in an endemic population Southeast Asian Journal of Tropical Medicine and Public Health 26(1): 38-45